BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18727021)

  • 21. Nd:YAG laser in caries prevention: a clinical trial.
    Zezell DM; Boari HG; Ana PA; Eduardo Cde P; Powell GL
    Lasers Surg Med; 2009 Jan; 41(1):31-5. PubMed ID: 19143016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
    Prasad R; Koul V; Anand S; Khar RK
    Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel.
    Singka GS; Samah NA; Zulfakar MH; Yurdasiper A; Heard CM
    Eur J Pharm Biopharm; 2010 Oct; 76(2):275-81. PubMed ID: 20600884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The enhancing effect of electroporation and iontophoresis on the permeation of insulin through human skin].
    Pan Y; Zhao HY; Zheng JM
    Yao Xue Xue Bao; 2002 Aug; 37(8):649-52. PubMed ID: 12567783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
    Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT
    J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
    Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
    J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting.
    Ali MF; Salah M; Rafea M; Saleh N
    Med Sci Monit; 2008 Dec; 14(12):PI66-74. PubMed ID: 19043379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil.
    Gómez C; Costela A; García-Moreno I; Llanes F; Teijón JM; Blanco D
    Lasers Surg Med; 2008 Jan; 40(1):6-12. PubMed ID: 18220260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser.
    Lee WR; Shen SC; Chen WY; Aljuffali IA; Suen SY; Fang JY
    Eur J Pharm Biopharm; 2014 Apr; 86(3):315-23. PubMed ID: 23962771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study.
    Lee WR; Tsai RY; Fang CL; Liu CJ; Hu CH; Fang JY
    Dermatol Surg; 2006 Aug; 32(8):1013-22. PubMed ID: 16918563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of photoablation of rabbit corneas by Er:YAG laser.
    Cubeddu R; Brancato R; Sozzi C; Taroni P; Trabucchi G; Valentini G; Verdi M
    Lasers Surg Med; 1996; 19(1):32-9. PubMed ID: 8836994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A.
    Liu H; Li S; Pan W; Wang Y; Han F; Yao H
    Int J Pharm; 2006 Dec; 326(1-2):32-8. PubMed ID: 16949776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil.
    Lee WR; Shen SC; Wang KH; Hu CH; Fang JY
    J Pharm Sci; 2002 Jul; 91(7):1613-26. PubMed ID: 12115823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation.
    Taudorf EH; Lerche CM; Vissing AC; Philipsen PA; Hannibal J; D'Alvise J; Hansen SH; Janfelt C; Paasch U; Anderson RR; Haedersdal M
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1059-69. PubMed ID: 25893560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of a single-wavelength fractional laser and a novel multi-wavelength fractional laser in the treatment of photodamaged skin.
    Geraghty LN; Biesman B
    Lasers Surg Med; 2009 Aug; 41(6):408-16. PubMed ID: 19588529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics.
    Lee WR; Shen SC; Fang CL; Liu CR; Fang JY
    Lasers Med Sci; 2007 Nov; 22(4):271-8. PubMed ID: 17334674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs.
    Tokudome Y; Sugibayashi K
    J Control Release; 2004 Mar; 95(2):267-74. PubMed ID: 14980775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.
    Lee WR; Shen SC; Sung CT; Liu PY; Fang JY
    Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superficial erbium:YAG laser resurfacing of photodamaged skin.
    Pozner JN; Goldberg DJ
    J Cosmet Laser Ther; 2006 Jun; 8(2):89-91. PubMed ID: 16766487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.